Latest filing published 22 Dec 2023 for Medivir Aktiebolag, €3,814.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Bengt Anders Westermark: trading record in brief
Bengt Anders Westermark discloses dealings in 2 companies, chiefly Medivir AB and Medivir Aktiebolag. Between 16 November 2017 and 22 December 2023, the trades on record add up to 5 filings.
Every open-market trade on record is a purchase: 5 purchases worth €24k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2023, the count stands at 1 purchase and no sales.
The median purchase comes to €3,814.
On 22 December 2023 came the latest disclosure, an open-market purchase for €3,814 in Medivir Aktiebolag. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Bengt Anders Westermark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,000 shares@ SEK 2.6540.8% of flowBTA (betald tecknad aktie)ISIN SE0000273294FI:csv-aef598b5cc73b67a6b82Canonical exit: 21 Mar 2024 (T+90)
- 2,000 shares@ SEK 19.3054.1% of flowAktieISIN SE0000273294FI:csv-e51d01fc0016508b7fbbCanonical exit: 11 Sept 2019 (T+90)
- 2,000 shares@ SEK 16.0045.9% of flowAktieISIN SE0000273294FI:csv-446fd64d43b133127b18Canonical exit: 26 Jun 2019 (T+90)
- 2,000 shares@ SEK 37.00ISIN SE0000273294FI:csv-50cd83700c8fd7dab1baCanonical exit: 31 May 2018 (T+90)
- 1,000 shares@ SEK 61.00ISIN SE0000273294FI:csv-9dc82e9474cece9b007eCanonical exit: 14 Feb 2018 (T+90)
5 of 5 declarations